Archive

Dive into the 2025 Health in Review, reflecting on South Africa’s healthcare struggles and clinical successes in HIV and TB treatment.

National Treasury threatens health departments in Gauteng, KZN, the Free State, and the Northern Cape with administrative management.

Understanding the 1.4% SEP increase: why the pharmaceutical sector is urging a reconsideration of the price cap.

BHF highlights the unsustainability of current medical scheme increases. Learn about essential reforms needed for healthcare.

Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.

The CMS Industry Report 2024 reveals a surge in healthcare costs and an ageing population, forcing a shift in medical scheme strategies.

Discover how Pandemic Preparedness and Prevention efforts in South Africa aim to improve bio-surveillance and health security.

South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.

Remgro and MSC announce a Mediclinic restructuring deal that splits Southern African and Swiss assets to streamline healthcare operations.

NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity

SA faces a crisis in HIV treatment retention as 1.1 million patients disengage from care. The “Close the Gap” campaign aims to fix this.